clinical trial · NCT05590715
International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder
Autism Spectrum Disorder
brief summary
To determine sufficient number of biological and clinical markers to identify subgroups of potential best responders to a specific medication
started
Oct 13, 2022
primary completion
Mar 31, 2027
completion
May 31, 2027
last updated
Nov 17, 2026
official title
International, Multicentric, Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol